Clinical Trial Update: Evaluation of "Dose-dense Therapy" by S-HAM in Comparison to Conventionally Timed Double Induction in Patients With Acute Myeloid Leukemia (AML) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing dose-dense S-HAM therapy to conventionally timed double induction in acute myeloid leukemia has completed. The update confirms the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• S-HAM regimen

Snippet

Sponsor: Prof. Dr. Wolfgang Hiddemann | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED